<div class="table-responsive">
    <table class="table table-striped table-hover">
        <thead>
            <tr>
                
                <th scope="col">
                    <a href="?cresstrial=13929&amp;modal=1&amp;valnames=arms&amp;order=created_at">Created at</a>
                </th>
                <th scope="col">Source</th>
                
                <th scope="col">Raw Value</th>
                <th scope="col">Validated value</th>
            </tr>
        </thead>
        <tbody>
            
            <tr class="histvalue-row" histvalueid="414714" class="table-">
                
                <td>June 20, 2022, 7:32 p.m.</td>
                <td>irct</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PlaceboControl group 2: Receiving two intramuscular doses of a placebo at a 21-days interval&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 4: Receiving two intramuscular doses of 2.5*10^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 21-days interval&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 3: Receiving two intramuscular doses of 0.5*10^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 21-days interval&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PlaceboControl group 1: Receiving two intramuscular doses of a placebo at a 14-days interval&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 2: Receiving two intramuscular doses of 2.5*10^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 14-days interval&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 1: Receiving two intramuscular doses of 0.5*10^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 14-days interval&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;Receiving two intramuscular doses of 0.5*10^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 14-days interval &quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;Receiving two intramuscular doses of 2.5*10^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 14-days interval &quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;14 days interval&quot;, &quot;treatment_id&quot;: 2187, &quot;treatment_name&quot;: &quot;Placebo&quot;, &quot;treatment_type&quot;: &quot;Placebo&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;Receiving two intramuscular doses of 0.5*10^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 21-days interval &quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;Receiving two intramuscular doses of 2.5*10^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 14-days interval &quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;21 days interval&quot;, &quot;treatment_id&quot;: 2187, &quot;treatment_name&quot;: &quot;Placebo&quot;, &quot;treatment_type&quot;: &quot;Placebo&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="404128" class="table-">
                
                <td>May 9, 2022, 6 a.m.</td>
                <td>irct</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PlaceboControl group 2: Two times placebo in the deltoid muscle (IM) at 21-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 4: Two times vaccines in the deltoid muscle (IM) with a dose of 2.5*10^6 (TCID50) equivalent to 10 \u03bcg/dose at 21-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 3: Two times vaccines in the deltoid muscle (IM) with a dose of 0.5*10^6 (TCID50) equivalent to 5 \u03bcg/dose at 21-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PlaceboControl group 1: Two times placebo in the deltoid muscle (IM) at 14-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 2: Two times vaccines in the deltoid muscle (IM) with a dose of 2.5*10^6 (TCID50) equivalent to 10 \u03bcg/dose at 14-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 1: Two times vaccines in the deltoid muscle (IM) with a dose of 0.5*10^6 (TCID50) equivalent to 5 \u03bcg/dose at 14-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;5 \u03bcg/dose at 14-day intervals&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;10 \u03bcg/dose at 14-day intervals&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;5 \u03bcg/dose at 21-day intervals&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;10 \u03bcg/dose at 21-day intervals&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;14-day intervals&quot;, &quot;treatment_id&quot;: 2187, &quot;treatment_name&quot;: &quot;Placebo&quot;, &quot;treatment_type&quot;: &quot;Placebo&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;21-day intervals&quot;, &quot;treatment_id&quot;: 2187, &quot;treatment_name&quot;: &quot;Placebo&quot;, &quot;treatment_type&quot;: &quot;Placebo&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}]
        </p>
        
    
                </td>
            </tr>
            
            <tr class="histvalue-row" histvalueid="312581" class="table-">
                
                <td>March 9, 2021, 1 a.m.</td>
                <td>irct</td>
                
                <td class="histvalue-container">
                    

        <p class="arms">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PlaceboControl group 2: Two times placebo in the deltoid muscle (IM) at 21-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 4: Two times vaccines in the deltoid muscle (IM) with a dose of 2.5*10^6 (TCID50) at 21-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 3: Two times vaccines in the deltoid muscle (IM) with a dose of 0.5*10^6 (TCID50) at 21-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PlaceboControl group 1: Two times placebo in the deltoid muscle (IM) at 14-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 2: Two times vaccines in the deltoid muscle (IM) with a dose of 2.5*10^6 (TCID50) at 14-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}, {&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: null, &quot;treatment_name&quot;: &quot;TODO PreventionIntervention group 1: Two times vaccines in the deltoid muscle (IM) with a dose of 0.5*10^6 (TCID50) at 14-day intervals&quot;, &quot;treatment_type&quot;: &quot;TODO&quot;, &quot;pharmacological_treatment&quot;: &quot;TODO&quot;}]
        </p>
    

                </td>
                <td class="histvalue-container">
                    

        <p class="arms validated">
            [{&quot;arm_notes&quot;: &quot;&quot;, &quot;treatment_id&quot;: 2187, &quot;treatment_name&quot;: &quot;Placebo&quot;, &quot;treatment_type&quot;: &quot;Placebo&quot;, &quot;pharmacological_treatment&quot;: &quot;Placebo&quot;}, {&quot;arm_notes&quot;: &quot;0.5x10^6;2;IM;Day0-14&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;2.5x10^6;2;IM;Day0-14&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;0.5x10^6;2;IM;Day0-21&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}, {&quot;arm_notes&quot;: &quot;2.5x10^6;2;IM;Day0-21&quot;, &quot;treatment_id&quot;: 1922, &quot;treatment_name&quot;: &quot;Inactivated sars-cov-2 vaccine fakhravac (mivac)&quot;, &quot;treatment_type&quot;: &quot;Inactivated virus&quot;, &quot;pharmacological_treatment&quot;: &quot;Vaccine&quot;}]
        </p>
        
    
                </td>
            </tr>
            
        </tbody>
    </table>
</div>
Created at	Source	Raw Value	Validated value
June 20, 2022, 7:32 p.m.	irct	[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group 2: Receiving two intramuscular doses of a placebo at a 21-days interval", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 4: Receiving two intramuscular doses of 2.510^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 21-days interval", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 3: Receiving two intramuscular doses of 0.510^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 21-days interval", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group 1: Receiving two intramuscular doses of a placebo at a 14-days interval", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 2: Receiving two intramuscular doses of 2.510^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 14-days interval", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 1: Receiving two intramuscular doses of 0.510^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 14-days interval", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "Receiving two intramuscular doses of 0.510^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 14-days interval ", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Receiving two intramuscular doses of 2.510^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 14-days interval ", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "14 days interval", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "Receiving two intramuscular doses of 0.510^6 (TCID50) strength of the vaccine equivalent to 5 \u03bcg/dose at a 21-days interval ", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Receiving two intramuscular doses of 2.510^6 (TCID50) strength of the vaccine equivalent to 10 \u03bcg/dose at a 14-days interval ", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "21 days interval", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
May 9, 2022, 6 a.m.	irct	[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group 2: Two times placebo in the deltoid muscle (IM) at 21-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 4: Two times vaccines in the deltoid muscle (IM) with a dose of 2.510^6 (TCID50) equivalent to 10 \u03bcg/dose at 21-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 3: Two times vaccines in the deltoid muscle (IM) with a dose of 0.510^6 (TCID50) equivalent to 5 \u03bcg/dose at 21-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group 1: Two times placebo in the deltoid muscle (IM) at 14-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 2: Two times vaccines in the deltoid muscle (IM) with a dose of 2.510^6 (TCID50) equivalent to 10 \u03bcg/dose at 14-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 1: Two times vaccines in the deltoid muscle (IM) with a dose of 0.510^6 (TCID50) equivalent to 5 \u03bcg/dose at 14-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "5 \u03bcg/dose at 14-day intervals", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "10 \u03bcg/dose at 14-day intervals", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "5 \u03bcg/dose at 21-day intervals", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "10 \u03bcg/dose at 21-day intervals", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "14-day intervals", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "21-day intervals", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
March 9, 2021, 1 a.m.	irct	[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group 2: Two times placebo in the deltoid muscle (IM) at 21-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 4: Two times vaccines in the deltoid muscle (IM) with a dose of 2.510^6 (TCID50) at 21-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 3: Two times vaccines in the deltoid muscle (IM) with a dose of 0.510^6 (TCID50) at 21-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group 1: Two times placebo in the deltoid muscle (IM) at 14-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 2: Two times vaccines in the deltoid muscle (IM) with a dose of 2.510^6 (TCID50) at 14-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 1: Two times vaccines in the deltoid muscle (IM) with a dose of 0.510^6 (TCID50) at 14-day intervals", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]	[{"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}, {"arm_notes": "0.5x10^6;2;IM;Day0-14", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2.5x10^6;2;IM;Day0-14", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "0.5x10^6;2;IM;Day0-21", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2.5x10^6;2;IM;Day0-21", "treatment_id": 1922, "treatment_name": "Inactivated sars-cov-2 vaccine fakhravac (mivac)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}]